Gilead Cobicistat shows efficacy in Phase 3 Study
Cobicistat, a quad single-tablet regimen is a potent mechanism-based inhibitor of cytochrome P450 3A (CYP3A), an enzyme that metabolizes drugs in the body. The Study 114 is a
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
The new solutions are McKesson Ambulatory Pharmacy Solutions, ExpressRx Track and AcuDose-Rx. McKesson Ambulatory Pharmacy Solutions is a portfolio of purchasing, inventory, retail, reimbursement and consulting services that